Parkinson David Ross

President and CEO at ESSA Pharma Inc. · on record since Oct 1, 2020
Director at ABBOTT BIOTHERAPEUTICS CORP · on record since Dec 22, 2008
Director at Molecular Templates, Inc. · on record since Jun 1, 2010
Director at AMBIT BIOSCIENCES CORP · on record since May 21, 2013
Director at Dare Bioscience, Inc. · on record since Oct 31, 2014
Director at Forte Biosciences, Inc. · on record since Apr 12, 2017
Director at CTI BIOPHARMA CORP · on record since Jun 7, 2017
Director at ESSA Pharma Inc. · on record since Oct 1, 2020

Insider trading activity of Parkinson David Ross

Transactions on record: 50; since Jan 27, 2009

Open-market buys: 4; $94.7K

Open-market sells: 0

Companies traded: 7; last filing Oct 15, 2025

Figures computed from official regulatory filings — .

Companies where Parkinson David Ross has traded

ESSA Pharma Inc.8 tx · $94.7K · Oct 15, 2025
CTI BIOPHARMA CORP14 tx · Jun 26, 2023
Forte Biosciences, Inc.4 tx · Oct 4, 2019
Dare Bioscience, Inc.6 tx · $25K · Jan 5, 2017
Molecular Templates, Inc.6 tx · Jun 28, 2016
AMBIT BIOSCIENCES CORP4 tx · $128.4K · Nov 13, 2014
ABBOTT BIOTHERAPEUTICS CORP8 tx · $877.5K · Apr 23, 2010

Track record of Parkinson David Ross

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Parkinson David Ross

Co-insiders of Parkinson David Ross

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ESSA Pharma Inc.Listing unverified	Oct 15, 2025	Other	-65,675	—	n/a (No price was disclosed in the filing)		SEC
ESSA Pharma Inc.Listing unverified	Mar 28, 2024	AwardD (derivative)	350,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Dec 18, 2023	Buy	9,223	2.30 USD	$21.2K	conv 35	SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-126,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-120,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-50,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Apr 7, 2023	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Jan 5, 2023	Buy	3,067	2.60 USD	$8K	conv 41Cluster	SEC
ESSA Pharma Inc.Listing unverified	Jan 5, 2023	Buy	21,367	2.39 USD	$51.1K	conv 60	SEC
ESSA Pharma Inc.Listing unverified	Nov 1, 2022	AwardD (derivative)	222,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Jul 5, 2022	Buy	4,887	2.96 USD	$14.5K	conv 38First in 12mo	SEC
CTI BIOPHARMA CORPListing unverified	Mar 11, 2022	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Mar 12, 2021	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Jan 11, 2021	AwardD (derivative)	266,948	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Mar 13, 2020	AwardD (derivative)	126,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forte Biosciences, Inc.Security delisted	Oct 4, 2019	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forte Biosciences, Inc.Security delisted	May 31, 2019	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	May 20, 2019	AwardD (derivative)	120,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forte Biosciences, Inc.Security delisted	Jun 25, 2018	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	May 17, 2018	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jun 7, 2017	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ESSA Pharma Inc.Listing unverified	Oct 15, 2025	Other	-65,675	—	n/a (No price was disclosed in the filing)		SEC
ESSA Pharma Inc.Listing unverified	Mar 28, 2024	AwardD (derivative)	350,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Dec 18, 2023	Buy	9,223	2.30 USD	$21.2K	conv 35	SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-126,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-120,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-50,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Jun 26, 2023	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
CTI BIOPHARMA CORPListing unverified	Apr 7, 2023	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Jan 5, 2023	Buy	3,067	2.60 USD	$8K	conv 41Cluster	SEC
ESSA Pharma Inc.Listing unverified	Jan 5, 2023	Buy	21,367	2.39 USD	$51.1K	conv 60	SEC
ESSA Pharma Inc.Listing unverified	Nov 1, 2022	AwardD (derivative)	222,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Jul 5, 2022	Buy	4,887	2.96 USD	$14.5K	conv 38First in 12mo	SEC
CTI BIOPHARMA CORPListing unverified	Mar 11, 2022	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Mar 12, 2021	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ESSA Pharma Inc.Listing unverified	Jan 11, 2021	AwardD (derivative)	266,948	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Mar 13, 2020	AwardD (derivative)	126,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forte Biosciences, Inc.Security delisted	Oct 4, 2019	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forte Biosciences, Inc.Security delisted	May 31, 2019	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	May 20, 2019	AwardD (derivative)	120,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forte Biosciences, Inc.Security delisted	Jun 25, 2018	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	May 17, 2018	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CTI BIOPHARMA CORPListing unverified	Jun 7, 2017	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC